Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans
Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans: a Prospective, Single-center, Observational Study
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
This observational or N/A phase trial investigates Arteriosclerosis Obliterans and is currently actively recruiting participants. First Affiliated Hospital, Sun Yat-Sen University leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Apr 2025 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
First recorded
Jul 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital, Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .